These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7696727)

  • 1. Rectal use of vancomycin.
    Bublin JG; Barton TL
    Ann Pharmacother; 1994 Dec; 28(12):1357-8. PubMed ID: 7696727
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
    Saffouri G; Khanna S; Estes L; Pardi D
    Am J Gastroenterol; 2014 Jun; 109(6):924-5. PubMed ID: 24896763
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
    Meuwissen SG; Rietra PJ; Mulder CJ; Reiss M; Visser J; Van Leeuwen AM
    Neth J Med; 1981; 24(1):10-3. PubMed ID: 7207690
    [No Abstract]   [Full Text] [Related]  

  • 6. [Infections with Clostridium difficile following antibiotic therapy].
    Scheppach W
    MMW Fortschr Med; 2009 Oct; 151(40):47-9. PubMed ID: 19927920
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Kuijper EJ; Wilcox MH
    Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959
    [No Abstract]   [Full Text] [Related]  

  • 8. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J
    Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
    Bartlett JG
    Clin Infect Dis; 2008 May; 46(10):1489-92. PubMed ID: 18419480
    [No Abstract]   [Full Text] [Related]  

  • 11. Clostridium difficile pancolitis in adults with cystic fibrosis.
    Barker HC; Haworth CS; Williams D; Roberts P; Bilton D
    J Cyst Fibros; 2008 Sep; 7(5):444-7. PubMed ID: 18585983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronidazole and vancomycin: equivalence of initial efficacy in CDAD.
    Burman LG
    Am J Gastroenterol; 2008 Aug; 103(8):2147; author reply 2147. PubMed ID: 18796117
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
    Chihara S; Shimizu R; Furukata S; Hoshino K
    Scand J Infect Dis; 2011 Feb; 43(2):149-50. PubMed ID: 20831355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
    Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meeting the challenge of recurrent Clostridium difficile infection.
    Johnson S
    J Hosp Med; 2012 Mar; 7 Suppl 3():S11-3. PubMed ID: 22407994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
    Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.